Combined together, these findings obtained from comprehensive metabolomic profiling of Fst transgenic mice provide compelling evidence that genetic manipulation of Fst in-vivo favorably alters the levels of key metabolites known to influence various aspects of metabolic conditions, and warrant future studies for the use of FST based therapeutic interventions to combat obesity and related diseases (168). Here, FST is linked to obesity due to melanocortin 4 receptor deficiency.